| ACTIVE |
| Grant ID |
Agency |
Title |
Dates |
PI |
Participants |
|
| |
Faculty |
Role |
| 7R56 LM007948-04A1 |
NIH/NLM 2 |
Causal Discovery Algorithms for Translational Research with High -Throughput Data |
10/15/09-10/14/10 |
Aliferis, CF |
|
|
| 3RO1 AR0566672-01S1 |
NIH/NIAMS |
The Pharmacology of Dermal Fibrosis |
09/23/09 – 9/22/11 |
Cronstein, B |
Aliferis, CF |
Co-Investigator |
| Statnikov, A |
Co-Investigator |
| 1 U54 RR024386-01A2 |
NIH/NCRR |
NYU-HHC Clinical Translation Science Award |
07/14/09 – 03/31/14 |
Cronstein, B |
Aliferis, CF |
Director, Biomedical Informatics Core |
| Alekseyenko, A |
Investigator |
| Brown, S |
Director, Bioinformatics Core |
| Chelico, J |
Investigator |
| Fu, L |
Investigator |
| Kluger, Y |
Investigator |
| Smith, PR |
Bioinformatics Operations Director |
| Statnikov, A |
Bioinformatics Service Manager |
| Triola, M |
Investigator |
| Zavadil, J |
Investigator |
| D43 TW007884-01 |
NIH/Fogarty International Center |
Promotion of Plasmodium Research and Training in India |
06/1/07-05/31/12 |
Carlton |
Brown, S |
Trainer |
| R01 DE13937-04A2 |
NIH/NIDCR |
Microbial Diversity and Genetic Characterization of Cariogenic Biofilms |
02/15/08 – 12/31/12 |
Caufield, P |
Brown, S |
Co-Investigator |
| UH2CA140233 |
NIH/NCI |
Foregut microbiome in development of esophageal adenocarcinoma |
04/01/09 – 03/30/10 |
Pei |
Brown, S |
Co-Investigator |
| G08 LM009535-02 |
NIH/NLM |
Web Services for Preventive Health |
9/30/08 – 9/29/11 |
Chelico, J |
|
|
| NCI R01 GM067132-07 |
NIH/NIGMS |
Role of the pRB family in Quiescence and Differentiation |
02/01/09-01/31/11 |
Dynlacht, BD |
Kluger, Y |
Co-Investigator |
| NIH R01 1R01DK081641-0 |
NIH/NIDDK |
Mechanism and Significance of Nonsense Mediated RNA Decay Regulation in Erythropo |
07/01/08-06/30/13 |
Gardner |
Kluger, Y |
Co-Investigator |
| NIH P50 CA121974 |
NIH/NCI |
Yale SPORE in Skin cancer |
07/01/07-06/30/11 |
Halaban |
Kluger, Y |
Co-Investigator |
| NYSSCR-NO8G-094 |
New York State Stem Cell Research |
Functional Identification of Transcriptional Determinants of the ES Cell State and Early Lineage Commitment |
4/1/09-3/31/11 |
Dailey, L |
Kluger, Y |
Co-Investigator |
| NCI R01 CA077245 |
NIH |
The Role of pRB and Co-repressors in Transcriptional Regulation |
|
Dynlacht, BD |
Kluger, Y |
Co-Investigator |
| 03T-483 |
Stanley Medical Research Institute |
Multi-Center Controlled Clinical Trial of D-Serene vs. Placebo in Patients with Persistent Negative and Cognitive Symptoms of Schizophrenia |
04/01/04 – 03/31/10 |
Javitt |
Robinson, JA |
Co-Investigator |
| U01 MH074356 |
NIH/NIMH |
D-Serine Treatment of Schizophrenia |
09/30/05- 08/31/10 |
Javitt |
Robinson, JA |
Co-Investigator |
| U10 DA013046 |
NIH/NIDA |
NIDA Clinical Trials Network – New York Node |
2/20/00 – 8/31/10 |
Rotrosen |
Robinson, JA |
Co-Investigator |
| U10 DA013035 |
NIH/NIDA |
NIDA Clinical Trials Netwwork - Long Island Regional Node |
9/1/99- 8/31/10 |
Nunes, E |
Robinson, JA |
Co-Investigator |
| U01 MH60903 |
NIH/NIMH |
Methylphenidate Efficacy and Safety in ADHD Preschools – Follow Up |
12/01/99 - 5/31/10 |
Greenhill |
Robinson, JA |
Co-Investigator |
| |
Eli Lilly Pharmaceuticals |
Treatment of Schizophrenia with Long-Acting 1st & 2nd Generation Antipsychotics at Inpatient Psychiatric Facilities |
5/01/07 – 3/31/10 |
Robinson, JA |
|
|
| R01MH081218 |
NIMH/NYUSOM |
Neural Substrates of Variability in ADHD |
7/10/08-5/31/11 |
Castellanos |
Robinson, JA |
PI of Subcontract |
| RFP-NIMH-08-DS-00009 |
NIMH/Feinstein Institute/The Zucker Hillside Hospital |
Recovery After an Initial Schizophrenic Episode (RAISE) |
3/01/09-2/28/17 |
Kane |
Robinson, JA |
PI of Subcontract |
| R01MH083246 |
NIMH/NYU Medical School |
Functional and Structural Connectivity in Adult ADHD Study |
2/15/09-11/30/11 |
Castellanos |
Robinson, JA |
PI of Subcontract |
| AQW051A2202 |
Novartis Pharmaceutical Corp. |
A single-dose, placebo-controlled, stratified, randomized, double-blind, crossover study to determine the pharmacodynamic effects of AQW051 followed by a 2-week multiple-dose, placebo-controlled, stratified, randomized, double-blind, parallel-group safety and tolerability study in patients with chronic stable schizophrenia. |
9/16/08 – 6/27/10 |
Robinson, JA |
|
|
| 1 I01 CX000242-01 |
Department of Veterans Affairs |
Molecular Biomarkers of Small Cell Lung Cancer Behaviour |
10/1/09 – 9/30/13 |
Massion, P |
Statnikov, A |
Co-Investigator |
| G08 LM009535-02 |
NIH/NLM |
Web Services for Preventive Health |
9/30/08 – 9/29/11 |
Triola, M |
|
|
| |
Josiah Macy Jr. Foundation |
NYU 3T: Teaching, Technology, Teamwork |
7/1/09 – 6/31/13 |
Triola, M |
|
|
| D1BIT10737 |
Congressionally-Mandated Health Information Technology Grants (D1B) |
NYUMC: Federated Research Data Warehouse |
9/1/08-8/31/2010 |
Cronstein, B |
Triola, M |
Co-Investigator |
| 5 P01 ES004068-20 |
NIH/NIEHS |
Molecular Toxicology of DNA Adducts |
07/01/07-06/30/12 |
Grollman |
Zavadil, J |
Co-Investigator |
| 5 P30 CA16087-28 |
NIH/NCI |
Cancer Center Support Core Grant |
03/01/08-02/28/14 |
Carroll |
Zavadil, J |
Co-Investigator |
| R21 HL094826 |
NIH/NHLBI |
TB Diagnosis Based on Promiscuous PE-PGRS Epitopes |
04/01/09-03/31/11 |
Laal |
Zavadil, J |
Co-Investigator |
